Results 1 to 10 of about 5,588,761 (314)
Hormonal therapy in uterine sarcomas
Uterine sarcomas (USs) are a group of rare but aggressive uterine malignancies, accounting for only 1% of the malignant tumors of female reproductive organs. Due to the high rate of recurrence and metastasis, the prognosis of USs is poor.
Yuqin Zang +6 more
doaj +2 more sources
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. [PDF]
Cancer remains a major global health challenge, consistently ranking as the second leading cause of mortality worldwide. Despite significant advancements in research and technology, the need to deepen our understanding of tumor biology and improve ...
Zafar A +4 more
europepmc +2 more sources
Hormonal therapies and venous thrombosis: Considerations for prevention and management
Background Venous thromboses are well‐established complications of hormonal therapy. Thrombosis risk is seen with both hormonal contraceptive agents and with hormone replacement therapy for menopause and gender transition.
Corinne LaVasseur +5 more
doaj +2 more sources
Profiling and hormonal therapy for acne in women
Acne vulgaris is the most common condition treated by physicians worldwide. Though most acne patients remit spontaneously, for the ones that do not or are unresponsive to conventional therapy or have obvious cutaneous signs of hyperandrogenism, hormonal ...
Sangita Ghosh +3 more
doaj +2 more sources
Past, present, and future of hormonal therapy in recurrent endometrial cancer
Matthew J Carlson, Kristina W Thiel, Kimberly K LeslieDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USAAbstract: Endometrial cancer is a heterogeneous disease.
Carlson MJ, Thiel KW, Leslie KK
doaj +2 more sources
Estetrol: a new estrogen component in combined oral contraceptives: A review [PDF]
Estetrol (E4) is a steroid hormone found in the urine of pregnant women in 1965. E4 is produced only during pregnancy and enters the maternal bloodstream through the placenta.
Aida U. Hamadyanova +7 more
doaj +1 more source
Background: Adherence to long-term adjuvant hormonal therapy in hormonal receptors (HR)-positive breast cancer is really challenging and can affect the survival outcome.
Shereef Ahmed Elsamany +5 more
doaj +1 more source
Hormonal Therapy for Prostate Cancer.
Huggins and Hodges demonstrated the therapeutic effect of gonadal testosterone deprivation in the 1940s and therefore firmly established the concept that prostate cancer is a highly androgen-dependent disease.
Kunal Desai +2 more
semanticscholar +1 more source
Simple Summary The most common therapies for severe and recurrent gynecological cancers are hormone therapy and chemotherapy, and responsiveness to therapy is a key component in prognosis and survivability.
Saikat Mitra +11 more
semanticscholar +1 more source
Background This study assesses the use of hormonal therapy to treat high-risk localized prostate cancer (HRLPCa) cases diagnosed between 2005 and 2015. Methods All N0-XM0 with ≥T3a, or PCa cases with poorly differentiated feature (equivalent to Gleason ...
Semaw Ferede Abera +4 more
doaj +1 more source

